<DOC>
	<DOC>NCT00318357</DOC>
	<brief_summary>The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.</brief_summary>
	<brief_title>CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up</brief_title>
	<detailed_description>The CARE-HF study enrolled 813 patients from 82 centers in 12 European countries (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, and UK). All patients that were reported to be alive in May 2005 will be asked to participate.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients who have participated in the CAREHF program and were reported to be alive in May 2005 Patients who signed a patient data release consent form Patients who have not participated in the CAREHF program Patients with exclusion criteria required by local legislation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Cardiac Resynchronization therapy (CRT)</keyword>
	<keyword>All-cause mortality</keyword>
	<keyword>Long-term follow-up</keyword>
</DOC>